Epidemiological and clinical features of pediatric COVID-19
2020 · BMC Medicine · 151 citations
https://doi.org/10.1186/s12916-020-01719-2
C
Chengxian Guo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
118
Papers
1.3K
Citations
21
h-index
42
i10-index
Chengxian Guo is an academic researcher from University of Science and Technology of China. The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Drug Transport and Resistance Mechanisms & Pharmacological Effects and Toxicity Studies. The author has an h-index of 21, co-authored 101 publications.
ORCID: 0000-0002-6332-6716Papers by this author
worksAnoikis in cell fate, physiopathology, and therapeutic interventions
2024 · MedComm · 33 citations
https://doi.org/10.1002/mco2.718
The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012–2015
2022 · BMC Public Health · 32 citations
https://doi.org/10.1186/s12889-022-14263-w
A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China
2021 · Frontiers in Pharmacology · 26 citations
https://doi.org/10.3389/fphar.2021.682020
Repaglinide-irbesartan drug interaction: effects of SLCO1B1 polymorphism on repaglinide pharmacokinetics and pharmacodynamics in Chinese population
2018 · European Journal of Clinical Pharmacology · 15 citations
https://doi.org/10.1007/s00228-018-2477-6
Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang
2020 · BMC Gastroenterology · 11 citations
https://doi.org/10.1186/s12876-020-01227-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat